Diagnostics Accelerator News Today

/PRNewswire/ - RetiSpec, Inc., an innovator in AI-powered eye diagnostics for brain health, and Topcon Healthcare, Inc. a leading provider of medical devices...

Most Alzheimers drug trials are using paper measurement tools developed in the 1980s and 1990s. Neurotechnology can do better for patients, while saving us billions.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this...

/PRNewswire/ -- The Alzheimers Drug Discovery Foundation (ADDF) has presented Rhoda Au, PhD, MBA, Professor of Anatomy and Neurobiology at the Boston...

ALZpath, a developer of blood-based diagnostic biomarker testing for Alzheimers disease detection receives funding from ADDFs

ALZpath received new funding for developing diagnostic solutions for Alzheimers disease, which 6.7 million Americans age 65 and older are living with in 2023.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Optina Diagnostics pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of...

Wyss Diagnostics Accelerator seeks to fast-track disruptive diagnostic technologies to meet unmet critical needsREGENSBURG, Germany & BOSTON--(BUSINESS WIRE)--Lifespin GmbH, based in Regensburg with offices in Boston, Massachusetts, announced today that it is one of 24 inaugural members of the Wyss Institute for Bio...